NEW YORK CITY, NY / ACCESS Newswire / February 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential ...

As an enterprise engaged in the development, manufacturing and commercialization of specialty plasma-derived therapeutics, ...

Teva's stock is a speculative buy with potential upside if biosimilars succeed, but risks remain high due to debt and ...

The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.

DelveInsight's High Potency Active Pharmaceutical Ingredients Market Insights report provides the current and forecast market ...

Pulmonary Or Respiratory Drug Delivery Global Market Report 2025 – Market Size, Trends, And Global Forecast 2025-2034 The Business Research ...

NORTHAMPTON, MA / / February 27, 2025 / In high-income countries, more than 80% of children diagnosed with cancer will survive. Yet in some low- and middle-income countries, this number ...

NORTHAMPTON, MA / ACCESS Newswire / February 27, 2025 / In high-income countries, more than 80% of children diagnosed with ...

We recently compiled a list of the 12 Best Low Price Pharma Stocks To Invest In Right Now. In this article, we are going to ...

Parsippany, New Jersey Thursday, February 27, 2025, 13:00 Hrs [IST] ...

The application leverages existing clinical data for Uzedy along with prior FDA findings on the safety of Udezy in patients ...